Literature DB >> 30913009

CAUSES AND PREDICTORS FOR 30-DAY RE-ADMISSIONS IN ADULT PATIENTS WITH DIABETIC KETOACIDOSIS IN THE UNITED STATES: A NATIONWIDE ANALYSIS, 2010-2014.

Carolina R Hurtado, Alejandro Lemor, Franco Vallejo, Katherine Lopez, Rodrigo Garcia, Joseph Mathew, Rodolfo J Galindo.   

Abstract

OBJECTIVE: We aimed to determine the causes and predictors for 30-day re-admission following a hospitalization for diabetic ketoacidosis (DKA) in the United States.
METHODS: This retrospective cohort study analyzed data from the National Re-admission Database. We included adult patients with a primary discharge diagnosis of DKA, from 2010 to 2014. Our primary objective was to determine the frequency and causes for 30-day re-admission after an index hospitalization for DKA. We also performed multivariate regression analyses using covariates from the index admission to identify predictors for 30-day re-admissions.
RESULTS: Among 479,590 admissions for DKA, 58,961 (12.3%) were re-admitted within 30 days. Recurrent DKA represented 40.8% of all-cause re-admissions. In multivariate analysis, end-stage renal disease (odds ratio [OR], 2.13; 95% confidence interval [CI], 2.00 to 2.27; P<.001), Charlson Comorbidity Index ≥3 (OR, 2.49; 95% CI, 2.42 to 2.58; P<.001), discharge against medical advice (OR, 1.97; 95% CI, 1.86 to 2.09; P<.001), and drug use (OR, 1.78; 95% CI, 1.71 to 1.86; P<.001) were the most significant predictors for 30-day re-admission. About 50% of patients were re-admitted within 2 weeks after discharge.
CONCLUSION: In the U.S., about one in every eight patients with DKA is re-admitted within 30 days, with 40.8% representing recurrent DKA episodes. Patients with end-stage renal disease, high comorbidity burden, drug use, and/or leaving against medical advice represented the highest risk group for re-admissions. Future studies with interventions focusing on high-risk population are critically needed. ABBREVIATIONS: AKI = acute kidney injury; BMI = body mass index; CCI = Charlson Comorbidity Index; CI = confidence interval; DKA = diabetic ketoacidosis; DM1 = type 1 diabetes mellitus; DM2 = type 2 diabetes mellitus; ESRD = end-stage renal disease; ICD-9-CM = International Classification of Diseases, Ninth Edition, Clinical Modification; IQR = interquartile range; LOS = length of stay; NRD = National Re-admission Database; OR = odds ratio.

Entities:  

Mesh:

Year:  2019        PMID: 30913009     DOI: 10.4158/EP-2018-0457

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  7 in total

1.  Outcomes of Diabetic Ketoacidosis in Adults With End-Stage Kidney Disease: Retrospective Study Based on a National Database.

Authors:  Karthik Gangu; Sanket D Basida; Anitha Vijayan; Sindhu Avula; Aniesh Bobba
Journal:  Cureus       Date:  2022-05-06

2.  Biochemical Parameters of Diabetes Ketoacidosis in Patients with End-stage Kidney Disease and Preserved Renal Function.

Authors:  Rodolfo J Galindo; Francisco J Pasquel; Priyathama Vellanki; Cesar Zambrano; Bonnie Albury; Citlalli Perez-Guzman; Zheng Ziduo; Guillermo E Umpierrez
Journal:  J Clin Endocrinol Metab       Date:  2021-06-16       Impact factor: 5.958

3.  Causes of diabetic ketoacidosis among adults with type 1 diabetes mellitus: insulin pump users and non-users.

Authors:  Monica Flores; Maryam Amir; Ramsha Ahmed; Suleiman Alashi; Manshi Li; Xiaofeng Wang; M Cecilia Lansang; Mohammed J Al-Jaghbeer
Journal:  BMJ Open Diabetes Res Care       Date:  2020-12

Review 4.  Predicting and Preventing Acute Care Re-Utilization by Patients with Diabetes.

Authors:  Daniel J Rubin; Arnav A Shah
Journal:  Curr Diab Rep       Date:  2021-09-04       Impact factor: 4.810

5.  Management of hospitalized patients with mild to moderate diabetic ketoacidosis using a continuous insulin infusion protocol on a medical surgical ward and observation level of care: A retrospective cohort study.

Authors:  Michael S Yoo; Abraham Daniels; Rene A Maslow; John A Gomez; Nannette L Meyers; Pamela S Bohrer; Siamack Nemazie; Christina E Sanford; Emily A Peterson; Kendal L Hamann; Darcy E Walsh; Alison M O'Herlihy; Vivek Kumra
Journal:  Medicine (Baltimore)       Date:  2022-08-05       Impact factor: 1.817

6.  TREATMENT OF DIABETIC KETOACIDOSIS AND THE WEEKEND EFFECT AT AN URBAN TERTIARY-CARE CENTER.

Authors:  Alon Yehuda Mazori; Dana Larsen; Maham Qureshi; Vafa Tabatabaie
Journal:  Endocr Pract       Date:  2020-02-11       Impact factor: 3.443

7.  Clinical characteristics and outcomes of patients with end-stage renal disease hospitalized with diabetes ketoacidosis.

Authors:  Rodolfo J Galindo; Francisco J Pasquel; Maya Fayfman; Katerina Tsegka; Neil Dhruv; Saumeth Cardona; Heqiong Wang; Priyathama Vellanki; Guillermo E Umpierrez
Journal:  BMJ Open Diabetes Res Care       Date:  2020-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.